Poliomyelitisvaccin
Generic name
Poliomyelitisvaccin
Brand name
ATC Code
J07BF03
- Dosages
- Side effects in children
- Warnings & precautions in children
- Contra-indications in children
-
Interactions - PK
- Renal impairment
- References
Pharmacokinetics in children
No information is present at this moment.
dose recommendation of formulary compared to licensed use (on-label versus off-label)
No information is present at this moment.
Available formulations
No information is present at this moment.
Dosages
| Active immunization against poliomyelitis |
|---|
|
Renal impaiment in children > 3 months
No information available on dose adjustment in renal impairment.
The complete list of all undesirable drug reactions can be found in the national Summary of Product Characteristics (SmPC) – click here
Side effects in children
In very preterm infants (≤ 28 weeks), respiratory problems (apnea) have been reported.
The complete list of all contra-indications can be found in the national Summary of Product Characteristics (SmPC) – click here
Contra-indications
No information available on specific contra indications in children.
The complete list of all warnings and precautions can be found in the national Summary of Product Characteristics (SmPC) – click here
Warnings & precautions in children
The potential risk of apnea and the need to monitor respiratory functions for 48-72 hours should be considered in the case of primary immunization in very preterm infants (born ≤ 28 weeks gestation), especially those with a not yet fully developed respiratory system in the anamnesis. Since the benefit of vaccination in this group of children is great, the vaccination should not be withheld or postponed.
Interactions
The complete list of all interactions can be found in the national Summary of Product Characteristics (SmPC) – click here
VIRAL VACCINES
This pages provides a list of drugs from the same ATC class for comparison. This does not necessarily mean that these drugs are interchangeable.
| Encephalitis vaccines | ||
|---|---|---|
| J07BA02 | ||
| J07BA01 | ||
| Influenza vaccines | ||
|---|---|---|
| J07BB02 | ||
| Hepatitis vaccines | ||
|---|---|---|
| J07BC20 | ||
| J07BC02 | ||
| J07BC01 | ||
| Measles vaccines | ||
|---|---|---|
| J07BD52 | ||
| Rabies vaccines | ||
|---|---|---|
| J07BG01 | ||
| Rota virus diarrhea vaccines | ||
|---|---|---|
| J07BH01 | ||
| Varicella zoster vaccines | ||
|---|---|---|
| J07BK01 | ||
| Yellow fever vaccines | ||
|---|---|---|
| J07BL01 | ||
| Papillomavirus vaccines | ||
|---|---|---|
| J07BM03 | ||
| J07BM02 | ||
| Other viral vaccines | ||
|---|---|---|
| J07BX04 | ||
Reference
- Bilthoven Biologicals B.V., SmPC Poliomyelitis vaccin (multidose) (RVG 17642, 114720) 22-07-2020, www.geneesmiddeleninformatiebank.nl
Changes
Therapeutic Drug Monitoring
Overdose
